NasdaqGS - Nasdaq Real Time Price USD
Inhibrx Biosciences, Inc. (INBX)
93.72 +1.51 (+1.64%)
As of 1:09:02 PM EDT. Market Open.
Trade INBX on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for INBX
- Previous Close
92.20 - Open
95.12 - Bid 68.89 x 200
- Ask 119.66 x 200
- Day's Range
92.85 - 96.08 - 52 Week Range
13.97 - 155.29 - Volume
90,259 - Avg. Volume
427,441 - Market Cap (intraday)
1.375B - Beta (5Y Monthly) 3.32
- PE Ratio (TTM)
-- - EPS (TTM)
-8.39 - Earnings Date (est.) Aug 12, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
277.50
Recent News
View More
Performance Overview
Trailing total returns as of 6/15/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
INBX
18.63%
S&P 500 (^GSPC)
10.53%
1-Year Return
INBX
543.21%
S&P 500 (^GSPC)
26.59%
3-Year Return
INBX
702.34%
S&P 500 (^GSPC)
70.95%
5-Year Return
INBX
702.34%
S&P 500 (^GSPC)
78.17%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/12/2026
Market Cap
1.36B
Enterprise Value
1.37B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.10k
Price/Book (mrq)
212.28
Enterprise Value/Revenue
1.06k
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-36.06%
Return on Equity (ttm)
-354.69%
Revenue (ttm)
1.3M
Net Income Avi to Common (ttm)
-130.19M
Diluted EPS (ttm)
-8.39
Balance Sheet and Cash Flow
Total Cash (mrq)
161.66M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-89.11M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap undefined -
Industry -
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.